English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Bayer Corporation
Trending
+
Pharmaceuticals
Patient Daily
| Jan 30, 2026
Senate gridlock delays decision on rare disease priority review voucher program
+
Pharmaceuticals
Patient Daily
| Feb 3, 2026
Drug Channels President on 340B: 'no one knows where the 340B profits go, or which patients benefit'
+
Pharmaceuticals
Patient Daily
| Feb 2, 2026
Clinical trial landscape shifts globally as China increases role in innovation
+
Pharmaceuticals
Patient Daily
| Feb 5, 2026
FDA lifts hold on Intellia's phase III ATTR gene editing trial
No Results
